Article Information
History
- September 16, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lynn R. Gauthier, PhD1,4,6,†,
- Lye-Ann Robichaud, BA1,*,2,3,
- Maud Bouffard, PhD1,6,
- Frédérique Therrien, BA1,2,6,
- Sarah Béland, PharmD1,6,
- Marianne Bouvrette, MD1,*,4,5,
- Jennifer Gewandter, PhD, MPH7,
- Lucia Gagliese, PhD8,9,
- Robert H Dworkin, PhD7,10,
- Julie Lemieux, MD, M.Sc.1,11,
- Josée Savard, PhD1,2,6,
- Philip L. Jackson, PhD2,12,13,
- Michèle Aubin, MD, PhD1,4,
- Sophie Lauzier, PhD15,16,
- Bruno Gagnon, MD, M.Sc.1,4,6,
- Anne Dionne, M.Sc.1,11,15,
- Cindy Shobbrook, NP, RN, EC, MN14 and
- Pierre Gagnon, MD, FRCPC1,6,17
- 1CHU de Québec-Université Laval Research Center, Oncology Division, Quebec, Canada
- 2School of Psychology, Faculty of Social Sciences, Université Laval, Quebec, Canada
- 3Department of Psychology, Faculty of Arts and Science, Université de Montréal, Montreal, Canada
- 4Department of Family and Emergency Medicine, Faculty of Medicine, Université Laval, Quebec, Canada
- 5Department of Community Health Sciences, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada
- 6Université Laval Cancer Research Center, Quebec, Canada
- 7Department of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center School of Medicine and Dentistry, Rochester, United States of America
- 10Department of Neurology, University of Rochester Medical Center School of Medicine and Dentistry, Rochester, United States of America
- 8School of Kinesiology and Health Science, York University, Toronto, Canada
- 9Departments of Anesthesia and Psychiatry, University of Toronto, Toronto, Canada
- 11Centre des maladies du sein Deschênes-Fabia, CHU de Québec, Quebec, Canada
- 12Centre interdisciplinaire de Recherche en Réadaptation et Intégration Sociale (Cirris),, Quebec, Canada
- 13CERVO Research Center, Québec, Canada
- 14Waterloo Wellington Integrated Hospice Palliative Care Program, Waterloo, Canada
- 15Faculty of Pharmacy, Université Laval, Quebec, Canada
- 16CHU de Québec-Université Laval Research Center, Population Health and Optimal Health Practices Division, Quebec, Canada
- 17Department of Psychiatry and Neurosciences, Université Laval, Quebec, Canada
- ↵†Corresponding author:
Lynn Gauthier, PhD, CHU-de Quebec-Université Laval Research Center, 9 rue McMahon, Québec (QC), Canada, G1S 3R3. Tel : 418-525-4444 ext.15567; E-mail : lynn.gauthier{at}crchudequebec.ulaval.ca;
Posted September 16, 2021.
Factors associated with chemotherapy-induced peripheral neuropathy-related reduced taxane dose or premature discontinuation in women with early-stage breast cancer
